Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | IM |
allergic reaction to the plants; This non-serious case was reported by a consumer via sales rep and described the occurrence of allergic reaction in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included allergy (plant/pollen allergies). Additional patient notes included Other Products: Not Provided. In JUL-2024, the patient received the 1st dose of Shingrix (intramuscular, unknown deltoid). In AUG-2024, less than 2 months after receiving Shingrix, the patient experienced allergic reaction (Verbatim: allergic reaction to the plants). In AUG-2024, the outcome of the allergic reaction was unknown. The reporter considered the allergic reaction to be unrelated to Shingrix. The company considered the allergic reaction to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 07-AUG-2025 and 08-AUG-2025. The patient reported that she received her first Shingrix dose in JUL-2024 and had not yet had the 2nd dose. She reported that, after her first dose, she developed an allergic reaction to the plants in her new residential surroundings. Her doctor stated to her that it was due to plant/pollen allergies, and not Shingrix. The patient inquired about the Shingrix vaccine, noting that they had received the first dose the previous year. Due to other medical complications, they had been unable to follow up with the second dose and had not revisited the matter until the current year. Upon seeking guidance regarding the necessity of the second shot, they were informed that it was indeed required.
Allergy (plant/pollen allergies)
Comments: Other Products: Not Provided